Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nalmefene”

36 trials

Showing 20 of 36 results

Early research (Phase 1)Study completedNCT07543276
What this trial is testing

Pharmacokinetic (PK) Evaluation of Nalmefene Formulations

Who this might be right for
Opioid Overdose
Knoa Pharma LLC 13
Not applicableStudy completedNCT02492581
What this trial is testing

Use of Selincro and Impact on Usual Practice

Who this might be right for
Alcohol Dependence
University of Bordeaux 700
Post-approval studies (Phase 4)Study completedNCT00000437
What this trial is testing

Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)

Who this might be right for
AlcoholismSmoking
The Scripps Research Institute 60
Early research (Phase 1)Study completedNCT03129347
What this trial is testing

Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers

Who this might be right for
Opioid-Related Disorders
National Institute on Drug Abuse (NIDA) 14
Post-approval studies (Phase 4)Study completedNCT00000450
What this trial is testing

Naltrexone Maintenance Treatment of Alcoholism

Who this might be right for
Alcoholism
The Scripps Research Institute 159
Early research (Phase 1)Study completedNCT01969617
What this trial is testing

Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge

Who this might be right for
Alcohol Dependence
H. Lundbeck A/S 22
Post-approval studies (Phase 4)Ended earlyNCT02195817
What this trial is testing

Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care

Who this might be right for
Alcohol Dependence
H. Lundbeck A/S 378
Early research (Phase 1)Study completedNCT06719986
What this trial is testing

Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg

Who this might be right for
Opioid Overdose
Purdue Pharma LP 24
Large-scale testing (Phase 3)WithdrawnNCT06408714
What this trial is testing

Nalmefene vs Naloxone for the Treatment of Recurrent Respiratory Depression After Opioid Overdose

Who this might be right for
Opioid OverdoseOpiate Overdose
University of New Mexico
Post-approval studies (Phase 4)Study completedNCT02197598
What this trial is testing

Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use

Who this might be right for
Alcohol Dependence
H. Lundbeck A/S 45
Not applicableStudy completedNCT03096730
What this trial is testing

Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative Hyperalgesia

Who this might be right for
PainAnesthesia
Tianjin Medical University General Hospital 150
Early research (Phase 1)Study completedNCT04759768
What this trial is testing

Pharmacokinetic Evaluation of Intranasal Nalmefene

Who this might be right for
Pharmacokinetics
Opiant Pharmaceuticals Inc 68
Large-scale testing (Phase 3)Study completedNCT02382276
What this trial is testing

A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence

Who this might be right for
Alcohol Dependence
Otsuka Pharmaceutical Co., Ltd. 405
Large-scale testing (Phase 3)Study completedNCT00811720
What this trial is testing

Efficacy of Nalmefene in Patients With Alcohol Dependence

Who this might be right for
Alcohol Dependence
H. Lundbeck A/S 598
Testing effectiveness (Phase 2)UnknownNCT02934919
What this trial is testing

Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study

Who this might be right for
Impulse Control DisordersParkinson Disease
University Hospital, Clermont-Ferrand 30
Large-scale testing (Phase 3)Looking for participantsNCT05540288
What this trial is testing

NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions

Who this might be right for
Behavioural Addiction
Nantes University Hospital 266
Large-scale testing (Phase 3)Study completedNCT00812461
What this trial is testing

Efficacy of Nalmefene in Patients With Alcohol Dependence

Who this might be right for
Alcohol Dependence
H. Lundbeck A/S 678
Large-scale testing (Phase 3)Study completedNCT02364947
What this trial is testing

A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)

Who this might be right for
Alcohol Dependence
Otsuka Pharmaceutical Co., Ltd. 678
Early research (Phase 1)Study completedNCT05219669
What this trial is testing

Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens

Who this might be right for
Opioid Overdose
Opiant Pharmaceuticals Inc 24
Post-approval studies (Phase 4)Study completedNCT04713358
What this trial is testing

Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia

Who this might be right for
Resuscitation
RenJi Hospital 542
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation